Clinical value of needleless sling in treatment of female stress urinary incontinence

BACKGROUND Stress urinary incontinence(SUI)is a common disease in women.The emergence of the needle-free sling has led to a new clinical treatment for SUI in women.AIM To explore the clinical value of the needleless sling without acupuncture in the treatment of SUI in women.METHODS From February 2017 to November 2018,according to the order of admission,44 patients(mid-suspension group)were treated by tension-free transobturator urethral suspension,and 44 patients(non-acupuncture group)were treated with a needleless non-acupuncture band.The clinical effects of the two treatments were evaluated.RESULTS There was no significant difference between the two groups in the total clinical effectiveness rate(P=0.374),but intraoperative blood loss and visual analogue scale score at postoperative day 1 were significantly lower in the non-acupuncture suspension group than in the middle urethral suspension group(P=0.396).The incidence of complications in the needle-free sling group was significantly lower than that in the middle urethral suspension group(P=0.025).CONCLUSION The clinical effectiveness of acupuncture-free suspension in treating SUI in female patients is better than that of traditional tension-free transobturator mid-urethral suspension.

Ten-Year Outcomes of Transobturator Mid-Urethral Sling for Treatment of Stress Urinary Incontinence in Hong Kong Chinese Women with or without Reconstructive Pelvic Floor Surgery

Objective: To evaluate the outcomes of transobturator mid-urethral sling (TO-MUS) with or without reconstructive pelvic floor surgery (RPFS) in Chinese women with stress urinary incontinence (SUI) after 10 years. Methods: This was a prospective observational study on Chinese women undergoing the insertion of TO-MUS with or without RPFS. All patients were assessed at 1-year and 10-year by urodynamic study (UDS). Objective cure was defined as the absence of urine leakage during provocative maneuvers on filling cystometry. Data regarding subjective outcome (patient perception), quality of life changes (Urogenital Distress Inventory-short form (UDI-6), Incontinence Impact Questionnaire-short form (IIQ-7)) and adverse events were also collected. Results: Of 104 eligible patients, 99 patients completed the 10-year evaluation. 57 patients (57.6%) underwent TO-MUS only and 42 patients (42.4%) underwent TO-MUS with concomitant RPFS. At 10-year follow-up, the overall objective cure rate was 86.9% and overall subjective cure rate was 80.8%. In TO-MUS only group, the objective and subjective cure rates at 10-year were 84.2% and 78.9% respectively. In TO-MUS with RPFS group, the objective and subjective cure rates at 10-year were 90.5% and 83.3% respectively. Compared TO-MUS only group with TO-MUS with RPFS group, there were no statistically significant differences in objective cure rate (84.2% vs. 90.5%, p = 0.55) and subjective cure rate (78.9% vs. 83.3%, p = 0.58). Conclusion: TO-MUS is an effective treatment for SUI in Hong Kong Chinese women. Concomitant RPFS during the procedure of TO-MUS does not affect the success.

Long Term Follow up of the Solyx Single Incision Sling in the Treatment of Female Stress Urinary Incontinence (SUI)

Objectives: The Solyx System was developed to be easier and safer to use than other slings. It was the objective of this study to retrospectively assess the long-term safety and efficacy of the SolyxTM SIS Sling System. Methods: After IRB approval and informed consent, chart reviews with follow up phone questionnaires of 69 subjects implanted with the Solyx Sling were collected at 2 sites. All of the patients had SUI and had urethral hypermobility with a q-tip test of >30 degrees. All subjects underwent surgery from 12/2008 to 01/2010 with a mean follow up of 43 months (range 39 -49). Subjects included in this data collection had a mean age of 67 years (range 30 -87). The dominant type of incontinence within the study patients was SUI while 17/69 (25%) of the subjects also had a component of urge incontinence. 38/69 (55%) of study patients had concomitant procedures. Results: Long-term Solyx results showed 64/69 (93%) of patients were subjectively dry by questionnaire and were satisfied with their outcome. 63/69 (91%) would have the procedure again. There were 4 cases of denovo urge incontinence and 2 reports of transient retention. There were no serious adverse events including no bladder, bowel, vessel or nerve perforations and no erosions or extrusions. No pain was reported that was attributed to the implant. Conclusions: Chart review with follow phone questionnaires indicated that the Solyx Sling was a safe, efficacious and less-invasive option for patients requiring SUI surgery and that these results were sustainable for an average of 43 months.

The Suburethral Sling Transobturator Approach for Stress Urinary Incontinence Treatment in Women in the Maternity and Neonatology Center of Tunis (WTSC)

The authors, through a descriptive retrospective study have evaluated the results of surgical treatment, by Tension-Free Obturator tape (TOT) technique, of urinary incontinence in the first 68 patients operated in the Department “C” of Obstetrics and Gynecology of the Maternity and Neonatology Centre of Tunis (WTSC). The average age in those patients was 55.14 ± 8.47 years with extremes of 40 and 82 years. The majority of the patients (72%) were under the age of 60 years. In sixty-one patients (89%), no urine leak has been detected and they were healed. In three patients (4%) there was improvement with partial recovery. Three other (4%) did not notice any improvement after the surgery. No case of dysuria or rejection of the strip has been reported. It was concluded that the declared satisfaction rate is 93%.

Needleless Contasure versus TVT-O in Women with Stress Urinary Incontinence

Objectives: The aim of this thesis is to determine the clinical effectiveness, safety and cost-effectiveness of Single Incision needleless Mini-Slings compared with tension-free Standard Mid-urethral Sling in the surgical management of female stress urinary incontinence, but with less side effects. Methods: The study will be conducted in Zagazig University Hospitals. From 2018 to Sept. 2019, 40 cases were enrolled in the study and were randomized by envelope technique at the time of surgery to either a trans-obturator vaginal tape (TOT) or Needleless anti-incontinence procedure. The patients will be divided into 2 groups: Group 1 patient treated by standard sling (TOT). Group 2 those treated by mini-sling. Parameters in perioperative period such as operating time, intraoperative hemorrhage volume, length of stay in hospital, intraoperative complications, and postoperative pain of each patient were recorded. The sample size was calculated to be 40 cases (20 cases will be treated by standard slings, 20 case will be treated by mini-sling). Results: A total of 40 patients assessed for eligibility were randomized into Needleless groups. There were no significant differences in age, body mass index, process, parity, pad test or the assessment of preoperative quality of life between the two groups. In the perioperative period, statistically significant differences between the two groups were found in operating time, intraoperative hemorrhage volume, groin pain scores at 24 h after operation and length of stay in hospital (P < 0.001). After two weeks of follow-up, a statistically significant difference between the two groups was found in groin pain/femori-bus internus pain scores, but there were no significant differences in cure rates, pad test, complications or ICIQ-SF. After 1 year, there were no significant differences between the Needleless and TOT groups in cure rates, pad test, groin pain or ICIQ-SF (P > 0.05). Both groups registered a significant improvement in the quality of life (P < 0.001), but there were no significant differences between the two groups (P > 0.05). Conclusion: We conclude that compared with the TOT surgery, single-incision Needleless sling in the treatment of female stress urinary incontinence is simpler and quicker and has less hemorrhage during surgery as well as faster recovery and it also can obviously reduce the inguinal region pains after operation and shorten hospital stays. In summary, single-incision Needleless sling is a kind of convenient, safe and effective minimally invasive surgery for urinary incontinence.

Contemporary diagnostics and treatment options for female stress urinary incontinence

Stress urinary incontinence is not a deadly disease,but for the large population of women suffering from it,it is a very important issue.Especially in the continuously aging population all over the world,there is more and more need for treatment of this serious medical condition.Treatment of female stress urinary incontinence exists already for ages.In the 20th century invasive treatments like Burch colposuspension and pubovaginal slings were the mainstay of surgical treatments.The introduction of the midurethral sling made the procedure less invasive and accessible for more caregivers.Luckily there are many options available and the field is developing quickly.In recent years many new medical devices have been developed,that increase the number of treatment options available and make it possible to find a suitable solution for the individual patient based on subjective and objective results and the chances of complications.This manuscript provides an introduction to the therapeutical options that are available nowadays for female stress urinary incontinence.

Medium-term clinical efficacy and safety of single incision and modified trans-obturator mid-urethral slings for female stress urinary incontinence

Aims:To evaluate the medium term efficacy and safety of Altis and Solyx single incision slings(SIS)compared with tension-free vaginal tape(TVT)Abbrevo trans-obturator sling.We hypothesize that both SIS show little difference in efficacy and safety and perform similarly to TVT Abbrevo.Methods:We conducted an ambispective comparative cohort study of women with stress urinary incontinence who received a SIS in comparison to matched TVT Abbrevo subjects from a concurrent randomized controlled trial(RCT).Subjects were identified retrospectively,and prospectively invited for examination and questionnaires>12 months post-operatively.Exclusions included intrinsic sphincter deficiency,previous sling surgery,and others.Primary outcome was subjective cure[negative response to International Consultation Incontinence Questionnaire-Urinary Incontinence Short Form(ICIQ-UI SF)question 6,leakage during coughing/activity].Secondary outcomes include objective cure(negative cough stress test),functional outcomes,and adverse events.Results:Between 2012 and 2018,a total of 113 women received one of two SIS surgeries;Solyx(n=50)followed by the Altis(n=63);104 were available for final efficacy analysis.Mean follow-up was 21.7(Altis),46.0(Solyx),and 29.0(Abbrevo)months.Baseline characteristics were comparable between the groups.There was no significant differences in the subjective or objective cure rates between the groups,and no differences in functional outcomes such as patient global impression of improvement,and post-operative ICIQ-UI SF score.There was a low rate of mesh related complications and no differences seen between the groups.Conclusions:Despite being an underpowered study,Altis and Solyx SIS have favourable efficacy and safety profiles which are comparable to an established trans-obturator mid-urethral slings(MUS).

Treatment success of transobturator tape compared with tension free vaginal tape for stress urinary incontinence at 24 months: A randomized controlled trial

Objective: To compare the long term efficacy of transobturator Tape (TOT) with tension free vaginal tape (TVT) at 24 months postoperatively. Patients & Methods: 160 women with stress urinary incontinence (SUI) were randomly allocated to either TVT or TOT procedures and reviewed at 24 months after surgery. The primary outcomes were objective cure (a negative cough stress test, and a negative 1-hour pad test), and subjective cure (defined as “very much better” or “much better” improvement in the Patient Global Impression of Improvement scale). The secondary outcomes included incontinence related quality of life (using Urogenital Distress Inventory Questionnaire, and Incontinence Impact Questionnaire), and complications. Results: No statistical difference was reported in objective and subjective cure rates between both groups. Objective cure rate was 85.6% and 81.6% in the TOT and TVT groups respectively (P = 0.55). Subjective cure rate in the TOT and TVT groups were 87% and 83% respectively (P = 0.68). There were no significant differences in postoperative complications and incontinence related quality of life. However, the operating time was significantly shorter in the TOT group compared with the TVT group (22.6 ± 3.9, 27.1 ± 3;respectively, P < 0.001). Conclusion: TOT and TVT procedures were equally efficient and safe for treatment of SUI, with maintenance of high objective and subjective cure rates for 24 months. Longer follow-up is needed to confirm these results.

Single incision slings: Past, present, and future

Pubovaginal slings have become the gold standard to treat stress urinary incontinence. Traditionally, the sling referred to a suspensory that was placed under the urethra and brought through the retropubic space and anchored on either side of the midline. Since this original concept, there have been many materials used for the sling, and there have been many different anchoring approaches. Most agree that one of the best materials is polypropylene mesh. However, the means of anchoring the device and where best to have this anchorage placed is debatable. The options for anchoring simply include using darts vs not to hold the sling in place. The location of this anchorage, on the other hand, is much more controversial. The main locations are retropubic, transobturator, and via a single incision. The obturator and retropubic slings have become the standard of care over time. The single incision sling, on the other hand, is starting to be more acceptable which has resulted in it being used more frequently. The single incision relies on mainly anchoring the sling through the obturator internus muscle with possible inclusion of the obturator membrane. The purpose of this review article is to present the data that exists for the use of the single incision sling.

Single incision slings:Are they ready for real life?

AIM： To review of the efficacy and safety outcomes of different single incision slings （SIS） systems, also in comparison with traditional slings.METHODS： A literature search was conducted in PubMed/MEDLINE database. The research was re-stricted to randomized and/or prospective trials and retrospective studies, published after 2006, with at least 20 patients with non-neurogenic stress urinary incontinence （SUI）. The studies had to assess effcacy and/or safety of the SIS with a minimum follow-up of 12 mo. All the paper assessing the performance of tension free vaginal tape secur were excluded from this review. The fnal selection included 19 papers fulflling the aforementioned criteria. Two authors independently reviewed the selected papers.RESULTS： Four different SIS systems were analysed： Ajust , Ophira , Altis and MiniArc . The average objective cure rate was 88%. Overall no statistically significant differences were found between SIS and traditional mid-urethral slings （MUS） in terms of objective cure （all P 〉 0.005）. Only one paper showed a statistically lower success rate in MiniArc？ vs Advant-age？ slings （40% vs 90%） and higher rates of failure in the SIS group. Since there was a great variability in terms of tests performed, it was not possible to com-pare subjective cure between studies. The vast part of the studies showed no major complications after SIS surgery. We also observed very low reported pain rates in SIS patients. The RCTs on Ajust？ and MiniArc？, showed better outcomes in terms of post-operative pain compared to MUS. None of the patients reported long- term pain complains. CONCLUSION： SIS showed similar effcacy to that of traditional slings but lower short-term pain, complication and failure rates.

A retrospective comparative series comparing monarc and sparc suburethral slings

A Retrospective Comparative Series Comparing Monarc and Sparc Suburethral Slings. Introduction and Hypothesis: There are a number of suburethral slings used in current practice to treat female urinary incontinence. To date there has been a lack of larger comparative series. This paper aims to evaluate the effectiveness and complications of two types of suburethral sling. Methods: A retrospective comparative series comparing 113 consecutive Sparcsuburethral slings with 112 consecutive Monarc slings. Results: The success rate of SparcvsMonarc was similar at 6 weeks (96.1% vs 94.2%, NS) and at 6 months (96.0% vs 92.6%, NS). The Monarc procedure had less intraoperative bladder fenestrations & less postoperative urgency. Conclusions: Both procedures had a similar success rate, while the Monarc had less complications. Brief Summary: Both procedures had a similar success rate, while the Monarc had less complications of intraoperative bladder fenestration & postoperative urgency.

Cadaveric Assessment of Synthetic Mid-Urethral Sling Placement

Purpose: To determine if 3 types of mid-urethral synthetic slings are visually the same. Materials and Methods: A retropubic, obturator, and single incision sling was individually placed in three cadavers. Tension was set using a spacer (obturator and retropubic). Single incision sling (SIS) tension was set by visual inspection. Thirty physicians were asked to determine placement method, tension, and location of the 3 slings. Results: Physicians were composed of 5 urologists, 7 urogynecologist, and 18 general gynecologists, with an average of 53 slings performed per year. Conclusion: This study showed that after placement of a sling it is hard to tell how the sling was placed and that most physicians felt the SIS was tensioned the best and most likely at the mid-urethra.

Combination therapy for male erectile dysfunction and urinary incontinence

Urinary incontinence （UI） and erectile dysfunction （ED） are both very prevalent conditions. Insertion of an artificial urinary sphincter （AUS） and penile prosthesis （PP） is an effective and proven method of treatment for both conditions. With advancing age, as well as with increasing populations of patients radically treated for prostate cancer, the occurrence of both conditions found in the same patient is increasing. The purpose of this article was to analyze the available evidence for simultaneous surgical management of male ED and UI using prosthetic devices. The existing literature pertaining to dual implantation of AUS and PP was reviewed. The concomitant insertion of the PP with the male perineal sling was also considered. Concurrent ED and UI are increasingly seen in the post radical prostatectomy population, who are often younger and less willing to suffer with these conditions. Insertion of an AUS and PP, either simultaneously or as a two-stage procedure, appears to be a safe, efficacious and long-lasting method of treatment. The improvements in design of both the AUS and PP as well as the development of the single transverse scrotal incision have made simultaneous insertion of these prostheses possible. Dual implantation of the PP and male sling looks promising in a selected population. In conclusion, the insertion of the AUS and PP for the treatment of concurrent UI and ED is safe and effective. Simultaneous insertion of these prostheses in the same patient offers potential advantages in operative and recovery time and is associated with high patient satisfaction. Combination therapy should therefore be included in the arsenal of treatment of these conditions.

Can We Predict De Novo Urge Incontinence by Perineal Ultrasound?

Introduction: Urinary incontinence affects over 200 million people worldwide [1]. Tension free vaginal tape is the standard surgical treatment for stress urinary incontinence. De novo urge urinary incontinence is a long-term complication of this treatment with a significant impact in the quality of life of these patients. Objective: The major aim of this study is to assess the correlation between perineal ultrasonography findings and the incidence of de novo urge urinary incontinence. Material and Methods: A prospective observational study was designed. Patients with stress urinary incontinence diagnosed by clinical and urodynamic findings submitted to a tension-free vaginal tape surgery were included. International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and introital perineal ultrasound were performed before surgical intervention (I-STOP&copy). Clinical and ultrasound re-evaluation were executed six months after surgery. Stress urinary incontinence was defined according to the ICS-IUGA. Data were recorded using a Microsoft Access database and statistical analysis using SAS&copy. Results: Bladder thickness equal to or below 6 mm has a low positive predictive value (PPV, 0.55), but a negative predictive power (NPP) of 0.72. Following surgery, a slight increase in postvoid residue is observed. Considering demographic data, an increase of 5 points in body mass index (BMI) resulted in an odds ratio (OR) of 1.74 of presenting de novo urge urinary in continence. Conclusions: In patients submitted to a tension-free vaginal tape surgery, high BMI seems to be associated with a higher rate of de novo urge urinary incontinence. Preoperative bladder wall thickness below 6 mm seems predict absence of this complication.

RMUS术治疗混合性尿失禁中尿急症、急迫性尿失禁症状的疗效观察

目的探索经阴道经耻骨后无张力尿道中段吊带(RMUS)术治疗混合性尿失禁(MUI)中尿急症、急迫性尿失禁(UUI)症状的疗效。方法回顾性分析2018年1月—2020年12月上海交通大学医学院附属仁济医院采用RMUS术治疗的44例女性MUI患者的临床资料。44例患者术前压力诱发试验、尿道抬举试验均为阳性。27例患者术前完成国际尿失禁咨询委员会女性下尿路症状长问卷(ICIQ-FLUTS-LF)调查,44例患者接受尿动力学(UDS)检查,其中9例(20.5%)出现逼尿肌过度活动(DO)。所有患者RMUS术中均通过解剖定位调整吊带张力。分析手术治疗效果和患者尿失禁改善情况。结果本研究44例患者平均年龄(58.59±9.08)岁,身体质量指数24.71±2.77。术后2年完成电话随访40例,主观治愈率为85.0%(34/40)。在27例完成ICIQ-FLUTS-LF问卷的患者中,手术前后漏尿发生率[100%(27/27)vs.18.5%(5/27)]、压力性尿失禁(SUI)发生率[100%(27/27)vs.18.5%(5/27)]、UUI发生率[70.4%(19/27)vs.29.6%(8/27)]差异均具有统计学意义(P<0.05);患者手术前后夜尿(≥1次)、尿急症、尿痛、排尿踌躇、排尿费力、排尿中断、遗尿发生率差异无统计学意义(P>0.05)。根据术前UDS检查结果进行的患者亚组分析显示,术后2年DO组和无DO组患者的主观治愈率差异有统计学意义[(55.6%(5/9)vs.93.5%(29/31),P<0.05],且两组患者术后SUI发生率[66.7%(4/6)vs.4.8%(1/21)]和UUI发生率[66.7%(4/6)vs.19.0%(4/21)]差异均有统计学意义(P<0.05),但尿急症发生率[66.7%(4/6)vs.33.3%(7/21)]差异无统计学意义(P>0.05)。结论采用RMUS术治疗压力诱发试验和尿道抬举试验阳性的MUI患者有效,术后可改善患者的SUI和UUI症状,但对于尿急症无明显改善。此外,DO组患者术后2年的主观治愈率劣于无DO组。

经耻骨后尿道中段悬吊带术治疗女性复发性压力性尿失禁的中长期疗效

目的:探讨经耻骨后尿道中段悬吊带术(tension-free vaginal tape,TVT)治疗女性复发性压力性尿失禁(recurrent stress urinary incontinence,rSUI)的效果及临床疗效。方法:回顾性分析2016年1月至2020年6月于北京朝阳医院采用TVT治疗rSUI的患者,收集患者基本信息。使用国际尿失禁咨询委员会尿失禁问卷表简表(International Consultation on Incontinence questionnaire-short form,ICI-Q-SF)记录患者术前、术后1年、术后3年以上的尿失禁症状评分,比较ICI-Q-SF各项评分及总分变化,同时记录并比较患者术前、术后3年以上的尿失禁临床症状严重程度。结果:共纳入24例患者,其中1例在术后1年因脑血管意外死亡,余23例随访时间3.9~7.3年,平均随访时间(5.2±1.1)年。ICI-Q-SF总分中位数术前为20.0(16.0,21.0),术后1年及平均5年随访时为5.0(1.5,7.8)和6.0(3.0,9.0),与术前比较差异均有统计学意义(P<0.001);ICI-Q-SF各分项评分在术后1年及平均5年的随访中均较术前减低,差异具有统计学意义(P<0.001)。从尿失禁严重程度来看,术前所有患者表现为中-重度尿失禁;术后平均5年,87.0%(20/23)的患者无尿失禁或仅有轻度尿失禁,13.0%(3/23)的患者再次出现中-重度尿失禁(P<0.001)。结论:TVT对女性rSUI治疗有效,平均5年治愈和有效改善率达到87.0%。

盆底重建术后泌尿道网片/吊带暴露的手术处理——单中心经验

目的对盆底重建术后网片/吊带泌尿道暴露的手术干预方法及长期治疗结局进行分析探讨。方法对2011年11月—2020年9月四川大学华西医院泌尿外科收治的因经阴道盆底重建术后网片或吊带发生泌尿道暴露再次接受手术治疗的9例患者的临床资料进行回顾性分析,探讨其一般临床特点,再次手术方式及治疗结局。结果9例患者的中位年龄为53(39~73)岁,身体质量指数中位数为23.0(19.5~27.3)。6例患者既往因盆腔脏器脱垂接受经阴道网片植入术而于术后发生网片暴露,其中3例患者接受经阴道部分网片切除术、3例接受膀胱镜下钬激光消融手术。另外3例患者既往因尿失禁接受无张力尿道中段悬吊术而于术后发生吊带暴露,其中2例接受膀胱镜下部分网片切除术治疗,1例接受膀胱镜下钬激光消融手术治疗。9例患者的中位随访时间为69(16~121)个月。截至末次随访时所有患者均未再次发生网片暴露。结论经阴道途径及经尿道途径的网片/吊带切除术均是治疗盆底重建术后泌尿道网片/吊带暴露的有效手术方法。

支持性心理干预联合渐进性肌肉放松训练在无张力吊带尿道中段悬吊术患者中的护理效果

目的探讨支持性心理干预联合渐进性肌肉放松训练在无张力吊带尿道中段悬吊术患者中的护理效果。方法选取2021年1月至2023年3月于四川大学华西医院进行无张力吊带尿道中段悬吊术的136例压力性尿失禁患者为研究对象,在组间基线特征可比的原则上,采用随机数字表法分为对照组和观察组,每组68例。对照组给予常规护理干预,观察组在对照组的基础上于围手术期给予支持性心理干预联合渐进性肌肉放松训练。比较分析两组患者护理干预前后的心理弹性水平[Connor-Davidson心理弹性量表(CD-RISC)各维度评分]、自知力与自我效能[自知力与治疗态度问卷量表(ITAQ)评分、一般自我效能感量表(GSES)评分]、尿失禁症状与生活质量[泌尿生殖障碍量表简版(UDI-6)评分、尿失禁影响问卷简表(IIQ-7)评分、国际尿失禁咨询委员会尿失禁问卷简表(ICIQ-SF)评分]。比较分析两组患者护理干预后的临床疗效以及术后的并发症发生情况。结果护理干预前,两组患者的CD-RISC乐观、自强、坚韧各维度评分以及ITAQ评分、GSES评分、IIQ-7评分、UDI-6评分、ICIQ-SF评分比较差异均无统计学意义(P>0.05)。护理干预3个月后,两组患者的CD-RISC乐观、自强、坚韧各维度评分以及ITAQ评分、GSES评分均升高,且观察组高于对照组,差异均有统计学意义(P<0.05);两组患者的IIQ-7评分、UDI-6评分、ICIQ-SF评分均降低,且观察组低于对照组,差异均有统计学意义(P<0.05)。观察组患者护理干预3个月后的临床总有效率高于对照组,术后并发症总发生率低于对照组,差异均有统计学意义(P<0.05)。结论支持性心理干预联合渐进性肌肉放松训练可有效增强无张力吊带尿道中段悬吊术患者的心理弹性水平,改善患者的自知力和治疗依从性,提高患者的自我效能、生活质量和临床疗效,且可减少术后并发症的发生。

女性压力性尿失禁伴膀胱活动低下治疗新进展

压力性尿失禁(SUI)和膀胱活动低下症(UAB)均是女性下尿路功能障碍的常见类型,由于两者治疗机制相反,SUI合并UAB患者的治疗成为了临床棘手的问题。为提高对此类患者的诊疗水平,本文综述国内外UAB主要诊断标准并总结传统尿道中段悬吊术[耻骨后无张力尿道中段悬吊术(TVT)或经闭孔无张力尿道中段悬吊术(TOT)]和可调式尿道中段悬吊术[(经闭孔可调吊带(TOA)或Remeex系统]联合药物或间歇导尿的治疗经验,同时对干细胞注射、细胞因子疗法和基因治疗等前沿技术在此类患者的应用进行了展望,期望为临床医生和科研工作者提供参考。

耻骨后和经闭孔尿道中段悬吊术对不同分型压力性尿失禁疗效的长期随访

目的:评估耻骨后尿道中段悬吊术(tension-free vaginal tape,TVT)和经闭孔尿道中段悬吊术(trans-obturator tape,TOT)治疗不同分型女性压力性尿失禁(female stress urinary incontinence,FSUI)的长期疗效。方法:回顾性分析2008年1月至2016年6月于北京大学人民医院行尿道中段悬吊术(mid-urethral slings,MUS)的FSUI患者的临床资料,并对所有患者进行随访。根据患者腹压漏尿点压(abdominal leak point pressures,ALPP)对FSUI进行分型,ALPP≤60 cmH 2 O(1 cmH 2 O=0.74 mmHg)为尿道固有括约肌缺陷(intrinsic sphincter deficiency,ISD)型,ALPP>60 cmH 2 O为非ISD型。结合国际尿失禁咨询委员会尿失禁问卷表简表,根据患者术后漏尿症状较术前改善的程度,将手术疗效判定为治愈、好转或无效。通过分别对比ISD型、非ISD型患者中TVT术和TOT术的治愈率,来评估TVT术和TOT术对不同分型FSUI的疗效。结果:共170例FSUI患者纳入研究,患者年龄30~78岁,随访时间12~110个月,其中非ISD型患者共117例,30例行TVT术,治愈率86.7%(26/30), 87例行TOT术,治愈率 69.0%(60/87),TVT术较TOT术治愈率高,但卡方检验显示差异无统计学意义(χ^2 =3.589, P >0.05);ISD型患者共53例,16例行TVT术,治愈率87.5%(14/16), 37例行TOT术,治愈率51.4%(19/37),TVT术较TOT术治愈率高,卡方检验显示差异具有统计学意义(χ^2 =6.212, P <0.05)。结论: MUS治疗FSUI可取得满意的长期疗效,对于非ISD型患者,TVT术和TOT术两种方式治愈率相当,但对于ISD型患者,TVT术较TOT术治愈率更高。